Molecular Engineering of Ultrasmall Silica Nanoparticle-Drug Conjugates as Lung Cancer Therapeutics

PURPOSE: Small molecule inhibitors have had a major impact on cancer care. While treatments have demonstrated clinically promising results, they suffer from dose-limiting toxicities and the emergence of refractory disease. Considerable efforts made to address these issues have more recently focused...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Madajewski, Brian, Chen, Feng, Yoo, Barney, Turker, Melik Z., Ma, Kai, Zhang, Li, Chen, Pei-Ming, Juthani, Rupa, Aragon-Sanabria, Virginia, Gonen, Mithat, Rudin, Charles M., Wiesner, Ulrich, Bradbury, Michelle S., Brennan, Cameron
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7686858/
https://ncbi.nlm.nih.gov/pubmed/32723835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-0851
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados